deltatrials
Unknown PHASE2 INTERVENTIONAL 2-arm NCT05046561

Study to Reinforce Immunity (STRI) Phase 2 Clinical Trial

Study to Reinforce Immunity (STRI) - A Phase 2 Double-Blind, Randomized, Placebo-Controlled Study to Investigate The Safety and Efficacy of STRI Formula in Non-Hospitalized Participants With COVID-19

Sponsor: Eyecheck, Inc.

Conditions Covid19
Interventions Placebo STRI Formula
Updated 7 times since 2021 Last updated: Sep 8, 2022 Started: Nov 4, 2021 Primary completion: Dec 31, 2022 Completion: Aug 31, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Covid19 and is currently ongoing. Eyecheck, Inc. leads this study, which shows 7 recorded versions since 2021 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

~Oct 2021 – ~Dec 2021 · 2 months · monthly snapshotNot Yet Recruiting~Dec 2021 – ~Jul 2022 · 7 months · monthly snapshotRecruiting~Jul 2022 – ~Sep 2022 · 2 months · monthly snapshotRecruiting~Sep 2022 – ~Jul 2024 · 22 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotRecruiting~Sep 2024 – ~Oct 2024 · 30 days · monthly snapshotRecruiting~Oct 2024 – present · 21 months · monthly snapshotUnknown

Change History

7 versions recorded

  1. Oct 2024 — Present [monthly]

    Unknown PHASE2

    Status: Recruiting → Unknown

  2. Sep 2024 — Oct 2024 [monthly]

    Recruiting PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE2

  4. Sep 2022 — Jul 2024 [monthly]

    Recruiting PHASE2

  5. Jul 2022 — Sep 2022 [monthly]

    Recruiting PHASE2

▶ Show 2 earlier versions

  1. Dec 2021 — Jul 2022 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  2. Oct 2021 — Dec 2021 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Eyecheck, Inc.
Data source: Eyecheck, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations